News InnoCan Pharma Corporation

Equities

INNO

CA45783P5085

Pharmaceuticals

Market Closed - Canadian Securities Exchange Other stock markets 01:37:04 2025-12-12 pm EST			5-day change	1st Jan Change
8.700 ^CAD	0.00%		-19.44%	-36.26%

Dec. 10	InnoCan Announces Public Filing of Amended Registration Statement For Proposed U.S. Offering	MT
Nov. 27	Innocan Pharma Nine-month Operating Loss Stable, Revenue Fall 10%	MT

InnoCan Announces Public Filing of Amended Registration Statement For Proposed U.S. Offering	Dec. 10	MT
Innocan Pharma Announces Public Filing of Amended Registration Statement for Proposed U.S. Public Offering	Dec. 10	AQ
Innocan Pharma Nine-month Operating Loss Stable, Revenue Fall 10%	Nov. 27	MT
Innocan Pharma Reports Financial Results for Q3 2025, with Revenues at US $21.6M	Nov. 27	AQ
InnoCan Pharma Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025	Nov. 26	CI
InnoCan Pharma : Financial Statements as of September 30, 2025	Nov. 26	PU
InnoCan Pharma : MD&A Report For Nine Months Period Ended September 30, 2025	Nov. 26	PU
Innocan Pharma Corporation Announces Promising Translational Evidence from A Pain Relief Study of Repeated Lpt-Cbd Administration in Goats	Nov. 24	CI
Innocan Pharma Announces Promising Translational Evidence from a Pain Relief Study of Repeated LPT-CBD Administration in Goats	Nov. 24	AQ
Innocan Pharma announces promising results of LPT-CBD administered to Gottingen Minipigs, a well-known drug toxicology model	Nov. 20	AQ
Innocan Pharma to Present at the 2025 ThinkEquity Conference	Oct. 24	AQ
Innocan Pharma Corporation Announces Its Patent for Lpt-Cbd Is Allowed in Japan	Oct. 15	CI
Liposomal CBD Injection Technology (LPT-CBD) patent was allowed in Japan	Oct. 15	AQ
Innocan Pharma Partners With a Sanctuary For Injured Animals to Bring Remedy and Hope with its LPT-CBD injection	Sep. 18	AQ
Innocan Pharma Corporation Partners with Freedom Farm to Bring Remedy and Hope with its LPT-CBD Injection	Sep. 18	CI
Innocan Pharma's Poster on its Liposomal Synthetic CBD Technology Generates Interest at PAINWeek Conference	Sep. 15	AQ
CSE Bulletin: Consolidation - InnoCan Pharma Corporation (INNO)	Sep. 02	NE
InnoCan Pharma Plans One-for-65 Share Consolidation Ahead of Nasdaq Listing	Aug. 29	MT
Innocan Pharma announces details of proposed share consolidation	Aug. 29	RE
Innocan Pharma Announces Details of Proposed Share Consolidation	Aug. 29	AQ
InnoCan Pharma : MD&A Report For Six Months Period Ended June 30, 2025	Aug. 28	PU
InnoCan Pharma : Financial Statements as of June 30, 2025	Aug. 28	PU
InnoCan Pharma Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2025	Aug. 27	CI
Innocan Pharma announces first half of 2025 financial results	Aug. 27	RE
Innocan Pharma announces first half of 2025 financial results	Aug. 27	RE

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News InnoCan Pharma Corporation

Equities

INNO

CA45783P5085

Pharmaceuticals

Filters